Esketamine: Regulators and a confusing narrative

I recently shared a BMJ report that outlined the approval of Esketamine in Europe:

Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products Regulatory Agency] has been published in the BMJ:

The lead signatory to the Letter mentioned in the original BMJ article has outlined a different narrative [as published in the BMJ]:

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.